-
Global CEO slams Aussie pharma for failing to think differently
Lexicon Pharma CEO Professor Mike Exton says the ANZ industry has been stuck on the same PBS mantra for 20 years and it’s time they moved on.
2 days ago | In Industry, People, Reimbursement -
Does Australia need to think outside the PBS box?
OP-ED: Eli Lilly CEO Dave Ricks says his company is ‘open’ to new funding medicine schemes. Is it time for stakeholders to think differently about access?
2 days ago | In Patients, Products, Reimbursement -
First‑in‑class therapies come under TGA review
Newcomers for achondroplasia, cancer among 14 therapies accepted for evaluation. Is the TGA seeing signs of MFN slowdown or rebirth?
2 days ago | In Products, Regulatory -
Date set for Covid vaccines to move to NIP
Free vaccines for most of the population is coming to an end with only those populations considered at high risk eligible under the NIP.
2 days ago | In Products, Reimbursement, Vaccines -
Pharma expert proposes radical access rethink
Incentives for biotechs to commercialise innovations in Australia along with a private funding model to bridge the gap between TGA registration and the PBS.
5 days ago | In Industry, People, Reimbursement -
Greens side with Labor to block IAG report
A move by Senator Ruston to force the release of the IAG’s final report and roadmap was blocked, raising questions as to what Labor is hiding.
5 days ago | In Politics -
AbbVie executives join MA, Pharmac
Jodie Wilson appointed to key policy role in MA’s senior team as NZ head moves to Pharmac in significant gains for the industry associations.
5 days ago | In Industry, People
Comment
Respect goes both ways – even with media
A recent incident made me ponder the meaning of respect, particularly as it relates to journalism and the role of the Fourth Estate.
News In Brief
Gene therapy partnership targets sleep apnoea
Australia advances AAV gene therapy with new UNSW–VVMF collaboration on Optosleep program.
Top Reads
-
-
Wed Aug 12
Thanks so much for making me unemployed
-
-
-